Vivo Capital »

Engene Holdings shares owned by Vivo Capital

Quarter-by-quarter ownership of Engene Holdings (ENGNW) shares owned by Vivo Capital from 13F filings

Historical chart of Vivo Capital investment in Engene Holdings

Tip: Access up to 7 years of quarterly data

All positions including Engene Holdings held by Vivo Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Engene Holdings by Vivo Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $844k 285k 2.96

More positions owned by Vivo Capital

Terns Pharmaceuticals Common (TERN)
Cidara Therapeutics Common (CDTX)
Praxis Precision Medicines Common (PRAX)
Cogent Biosciences Common (COGT)
Trevi Therapeutics Common (TRVI)
Avadel Pharmaceuticals Adr (AVDL)
Compass Therapeutics Common (CMPX)
Dyne Therapeutics Common (DYN)
Abivax SA - Sponsored Ads (ABVX)
DBV Technologies SA Sponsored Ads (DBVT)
SAB Biotherapeutics Common (SABS)
Soleno Therapeutics Common (SLNO)
Bright Minds Biosciences Common (DRUG)
Sinovac Biotech SHS
Geron Corp Common (GERN)

View all positions for Vivo Capital

Top funds holding Engene Holdings

Fcpm Iii Services B.v.
BVF
Vivo Capital
Saba Capital Management
Calamos Advisors
Caption Management
D. E. Shaw & Co
LMR Partners
Millennium Management
Tenor Capital Management
Blue Owl Capital Holdings
CSS
Wolverine Asset Management
Toronto-Dominion Bank

View all funds holding Engene Holdings